Steven George Hughes, Chief Medical Officer at Avidity Biosciences, Inc. (RNA), sold 3,084 shares at $45.41 ($140K) on 2025-09-15, disclosed to the SEC on 2025-09-17.
Scheduled sale ($140k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.41 | 1,542 | $70K | 50.0% |
| 2 | $45.41 | 1,542 | $70K | 50.0% |
| Total | $45.41 avg | 3,084 | $140K | 100% |
| Filing → |
| RNA | SELL | 2025-10-24 | $210K | — | Filing → |
| RNA | SELL | 2025-09-23 | $179K | — | Filing → |
| RNA | SELL | 2025-08-22 | $205K | — | Filing → |